Radiotherapy would be the choice of treatment for human cancers, because of high cost-effectiveness. However, a certain population of patients shows a resistance to radiotherapy and recurrence. In an effort to increase the efficacy of radiotherapy, many efforts were driven to find the genes causing the unresponsiveness to ionizing radiation. In this paper, we compared the gene expression profiles of two lung cancer cell lines, H460 and H1299, which showed differential responses to ionizing radiations. Each cell were irradiated at 2 Gy, and harvested after 0, 2, 4, 8, 12 and 24 hours to examine the expressions. Two-way ANOVA analysis on time-series experiments of two cells could select 2863 genes differentially expressed upon ionizing radiation among 32,321 genes in microarray (p＜0.05). We classified these genes into 21 clusters by SOM clustering according to the interaction between cell types and time. Two SOM clusters were enriched with apoptosis-related genes in pathway analysis. One cluster contained higher levels of phosphatidyl inositol 3-phosphate kinase (PI3K) subunits in H1299, radio-resistant cells than H460, radiosensitive cells. TRAIL receptors were expressed in H460 cells while the decoy receptor for TRAIL was expressed in H1299 cells. From these results, we could characterize the differential responsiveness to ionizing radiation according to their differential expressions of apoptosis-related genes, which might be the candidates to increase the power of radiotherapy.
Introduction
Radiotherapy would play an important role in cancer treatment for long times and widely used to have more than one million patients received radiotherapy every year (Wu et al., 2002) . In some type of cancers at prostate and cervix, radiotherapy achieved high performance in cure rate in comparison to radical surgery. Moreover, it can be applied to organ conservation surgery in breast cancers and rectal cancers. However, a certain proportion of patients do not respond to radiotherapy, and the mechanism of radiation resistance has been the main target of research to increase the efficacy of radiotherapy.
Although single molecules were targeted to modulate the radiation responses at pre-clinical models, it was hard to be applied to patients. It might be due to the complexity of radiation responses as shown in gene expression profiling experiments . Recently miRNA also has been proposed to be important regulator of radiation responses (Weidhaas et al., 2007) . Gene expression profiling using microarray provided valuable tools for the clinical oncology to determine the prognosis of patients (Lossos et al., 2004; Pomeroy et al., 2002) , the molecular diagnosis (Golub et al., 1999) as well as the responsiveness to therapeutics (Snyder and Morgan, 2004) .
There have been many reports on the molecular pattern analysis using microarray to understand the chemoand radio-resistance in cervical cancer (Achary et al., 2000; Tewari et al., 2005; Wong et al., 2006) , rectal cancer (Kim et al., 2007) and esophageal cancer (Fukuda et al., 2004) . Most of the studies are to identify differentially expressed genes in patients with different clinical outcomes, which can be applied to the evaluation of prognosis more accurately. Although the conventional parameters like tumor stage and grade can be used to decide optimal cancer therapy, molecular markers would provide valuable information to make clinical decisions (Klopp and Eifel, 2006) . Genome-wide analysis on gene expression can predict the clinical consequences more accurately. In addition, the information from gene expression profiling can facilitate the development of biological target for therapeutics by identifying pathways and determining steps contributing to the phenotype.
In this study, we examined the expression profiles of two lung cancer cell lines, which showed differential re- 
Methods
Cell culture and ionizing radiation H460 and H1299 lung cancer cells were purchased from ATCC and maintained in high-glucose Dulbecco's Eagle's medium (DMEM; GIBCO/BRL, Gaithersburg, Md., USA) containing 10% heat-inactivated fetal bovine serum (FBS, GIBCO/BRL) and 50 U/ml gamma-interferon (Gemzyme, Cambridge, MA, USA).
After the exposure to ionizing radiation generated by 4MV linear accelerator (Clinac 4/100, Varian, Palo Alto, CA), cells were harvested at the indicated time. We repeated sets of experiment three times to collect biological triplicates in every sample.
Microarray and data analysis
Samples in each group were harvested in triplicates and total RNAs were extracted by dissolving in TriZol and the purification using Qiagen RNAeasy column . We used GeneChip Human Gene 1.0 ST array from Affymetrix which includes 32,000 human genes. Fluorescence intensity was processed and measured using Exon Microarray Analyzer. Intensity data were imported to an in-house microarray database as described previously (Lee et al., 2006) . Gene Ontology (GO) and pathway analysis
Differentially expressed genes were further analyzed using DAVID for GO analysis as well as pathway analysis (Dennis et al., 2003) .
Results and Discussion
To examine the molecular changes upon ionizing radiation, we used H460 and H1299 lung cancer cells, which show different responses to ionizing radiation in the clo- However, if we can compare the time-series expression patterns in parallel, it would be possible to detect the genes related to differential responses to ionizing radiation. Differentially expressed genes (DEGs) were selected by two-way ANOVA on two time-series data (p＜0.05).
Then these 2863 DEGs were further classified into 21 clusters according to their expression patterns using SOM (Fig. 1) . Fourteen out of 21 clusters containing more than 10 genes could be divided into two groups like RS and RR (Table 1 ). The level of transcripts in RS clusters are higher in radio-sensitive H460 cells than in H1299 cells, while RR cluster genes are expressed at higher levels in H1299 cells. RS group contained 7 clusters with 1272 genes, which were up-regulated in H460 We have characterized each clusters according to their GO terms over-represented in each cluster significantly (p＜0.05). As listed in Table 2 , RS clusters were enriched with GO terms related to the response to radiation, signal transduction, apoptosis and metabolism. For RR clusters, we could find the GO terms related to cell cycle, DNA damage and apoptosis (Table  3) . Using DAVID web-accessible program, we examined the KEGG pathways related to each cluster to understand the time-series data on the cellular responses to ionizing radiation (Table 4) . As GO analysis showed the enrichment of terms on biological process, apoptosis pathways were significantly changed in both of RS (RSC) and RR (RRE) clusters. In addition, metabolic and signaling pathways were selected in RS group, and cell cycle pathway in RR group.
RSC cluster contained 26 apoptosis-related genes (Table 2) , which were over-expressed in H460 cells, but not changed upon ionizing radiation. Caspases (CASP8 and CASP10), interleukins (IL1A, IL1B and IL6), TRAIL receptors (TNFRSF10A and TNFRSF10B) might play an important role in cell death upon ionizing radiation in H460 cells (Table 5 ). These genes were present in lower levels, and not induced by irradiation in H1299. RRL cluster contained the genes which were up-regulated in H1299 cells, and induced in H460 cells after 8 hours of irradiation. Among 6 genes, Survivin (BIRC5) and GADD45A might be related to radio-resistance of H1299 cells. RRE clusters in RR group contained 7 apoptosis-related genes like PI3K subunits (PIK3CA, PIK3CB and PIK3R4) and IRAK4. Many genes related to apoptosis were selected in two-way ANOVA analysis, and their differential activity to determine the radiation responses could be sorted out by SOM and pathway analysis.
Radiation sensitivity is usually determined by classical clonogenic assay in radiation biology. But it is not easy to establish cell line from the individual patient's specimen and too slow to be used as a routine work. As a result, there is no available clinical method to predict radiation response to radiation therapy. If we can predict individual response rate to radiation therapy, we can modify total dose and fractionation schedule of radiation therapy individually so as to increase therapeutic ratio.
We have examined the gene expression profiles to understand the underlying molecular changes in cells with different radiation sensitivity. From the differentially expressed genes, we can select the biomarkers to discriminate the radio-resistant tumors from radio-sensitive one. Using those genomic biomarkers, we can develop the platform to check the radiation response in radiotherapy patients. Further study is undergoing with patient's tumor specimen.
